Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visual Outcomes and Predictive Factors in Chinese Patients With DME Treated With Ranibizumab
NCT03973138Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2015
- Primary completion
- Jan 2020
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03973138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973138.